Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                FDA Organization

FDA Organization

                        


                        Office of the Commissioner
          Center for Biologics Evaluation and Research (CBER)
          Center for Devices and Radiological Health
          Center for Drug Evaluation and Research | CDER
          Center for Food Safety and Applied Nutrition (CFSAN)
          Center for Tobacco Products
          Center for Veterinary Medicine
          Office of Regulatory Affairs
          Oncology Center of Excellence
          FDA’s Proposal for a Unified Human Foods Program and New Model for the Office of Regulatory Affairs
          FDA Organization Charts Home
          About FDA
          FDA Organization
          Elizabeth JungmanFDA Organization Elizabeth 
         
                
                 Jungman 
         
                                    
    J.D.,    M.P.H.
        
                
                    Leadership Role
          Chief of Staff - Office of the Commissioner 
                
    Share
    Post
    Linkedin

    Email
    PrintElizabeth Jungman, J.D., M.P.H.


            Elizabeth  Jungman 
    J.D.,    M.P.H.As Chief of Staff of the FDA, Elizabeth Jungman, J.D., M.P.H. oversees the day-to-day management of the agency and leads agency activities on major initiatives. In this role, she provides strategic direction to senior leadership to advance the FDA’s policy priorities and works closely with the leadership of all FDA product centers and field operations to support the successful implementation of agency policies. She serves as the Commissioner’s direct liaison to other executive agencies and organizations and engages across government on critical public health initiatives. Ms. Jungman also plays a key role in legislative engagement, communications and stakeholder outreach.

Prior to the Chief of Staff role, Ms. Jungman worked in the FDA’s Center for Drug Evaluation and Research as Associate Director for Policy and Director of the Office of Regulatory Policy, helping to oversee the development of regulations, policies and procedures for human prescription and over-the-counter (OTC) drugs.

Before joining the FDA in 2019, Ms. Jungman worked for The Pew Charitable Trusts, first as Director of Drug Safety and Innovation, then as Director of Public Health Programs. She led projects on important issues such as antibiotic innovation and stewardship in both humans and animals; the FDA’s regulation of laboratory developed tests, regenerative medicine therapies, OTC drug products, dietary supplements and compounding; and policy to address substance use disorder.

From 2011 to 2013, Ms. Jungman was a Senior Health Policy Adviser with the U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP). While on the HELP Committee, she advised on legislative matters related to drugs, devices, veterinary products, foods and cosmetics, and played a crucial role in drafting and negotiating the Food and Drug Administration Safety and Innovation Act of 2012 and other health- and drug-related legislation, including pandemic preparedness, drug compounding and supply chain security.

Earlier in her career she was a member of a Washington, D.C.-based law firm advising on a broad range of food and drug, and health care matters.

Ms. Jungman holds a bachelor’s in biology from Harvard College, a law degree from Georgetown University Law Center, and a master’s in public health from Johns Hopkins School of Public Health.

Resources For You

FDA Leadership Profiles

                                                                                  Content current as of:
      01/29/2024FDA Organization

          
                        


                        Office of the Commissioner
          Center for Biologics Evaluation and Research (CBER)
          Center for Devices and Radiological Health
          Center for Drug Evaluation and Research | CDER
          Center for Food Safety and Applied Nutrition (CFSAN)
          Center for Tobacco Products
          Center for Veterinary Medicine
          Office of Regulatory Affairs
          Oncology Center of Excellence
          FDA’s Proposal for a Unified Human Foods Program and New Model for the Office of Regulatory Affairs
          FDA Organization Charts
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop